Table 5.
Linear regression analysis
| Creatinine at follow-up | |||
| Best single clinical parameter | Parameter estimate | p-value | adj R 2 |
| INSCO | 1.799 | 0.0012 | |
| Total | 0.0012 | 0.44 | |
| Creatinine at follow-up | |||
| Best clinical parameter combination | Parameter estimate | p-value | adj R 2 |
| INSCO | 1.472 | 0.0065 | |
| Crea_biopsy | 0.755 | 0.0834 | |
| Total | 0.0014 | 0.51 | |
| Creatinine at follow-up | |||
| Clinical parameters + CREDI genes | Parameter estimate | p-value | adj R 2 |
| INSCO | 1.277 | 0.0248 | |
| VEGFC | −0.812 | 0.0268 | |
| Total | 0.0009 | 0.51 | |
| Creatinine at follow-up | |||
| Clinical parameters + INSCO genes | Parameter estimate | p-value | adj R 2 |
| BMP7 | −0.67 | 0.0015 | |
| THBS1 | 1.160 | 0.0035 | |
| TRIB1 | 0.534 | 0.0007 | |
| Total | < 0.0001 | 0.94 |
Adjusted R2- and p-values for different models for prediction of follow-up creatinine are shown.